Symbol |
Name |
1060P11.3
|
killer cell immunoglobulin-like receptor, three domains, pseudogene
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
ADD3
|
adducin 3 (gamma)
|
ADM
|
adrenomedullin
|
AEBP1
|
AE binding protein 1
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
BEX1
|
brain expressed, X-linked 1
|
BLNK
|
B-cell linker
|
C10ORF10
|
chromosome 10 open reading frame 10
|
CCND2
|
cyclin D2
|
CD52
|
CD52 molecule
|
CDK12
|
cyclin-dependent kinase 12
|
CEP57
|
centrosomal protein 57kDa
|
CFB
|
complement factor B
|
CLEC2B
|
C-type lectin domain family 2, member B
|
CRABP2
|
cellular retinoic acid binding protein 2
|
CRIP1
|
cysteine-rich protein 1 (intestinal)
|
DDIT4
|
DNA-damage-inducible transcript 4
|
ECM1
|
extracellular matrix protein 1
|
ESR1
|
estrogen receptor 1
|
FCGBP
|
Fc fragment of IgG binding protein
|
GDF15
|
growth differentiation factor 15
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
HOXB2
|
homeobox B2
|
HSPA6
|
heat shock 70kDa protein 6 (HSP70B')
|
HSPA8
|
heat shock 70kDa protein 8
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
IER3
|
immediate early response 3
|
ISYNA1
|
inositol-3-phosphate synthase 1
|
LAPTM5
|
lysosomal protein transmembrane 5
|
LASP1
|
LIM and SH3 protein 1
|
LEF1
|
lymphoid enhancer-binding factor 1
|
LXN
|
latexin
|
MCAM
|
melanoma cell adhesion molecule
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
MEIS2
|
Meis homeobox 2
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
MLLT11
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11
|
MMD
|
monocyte to macrophage differentiation-associated
|
MMP11
|
matrix metallopeptidase 11
|
MPPED2
|
metallophosphoesterase domain containing 2
|
MTSS1
|
metastasis suppressor 1
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
PCGF2
|
polycomb group ring finger 2
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
PEG10
|
paternally expressed 10
|
PLIN2
|
perilipin 2
|
PRAF2
|
PRA1 domain family, member 2
|
PRAME
|
preferentially expressed antigen in melanoma
|
PTCH1
|
patched 1
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
QPCT
|
glutaminyl-peptide cyclotransferase
|
RFX5
|
regulatory factor X, 5 (influences HLA class II expression)
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
S100P
|
S100 calcium binding protein P
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
SCGB2A1
|
secretoglobin, family 2A, member 1
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
SFRP4
|
secreted frizzled-related protein 4
|
SLC2A5
|
solute carrier family 2 (facilitated glucose/fructose transporter), member 5
|
SLC35E2B
|
solute carrier family 35, member E2B
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
SORBS1
|
sorbin and SH3 domain containing 1
|
SPON1
|
spondin 1, extracellular matrix protein
|
SST
|
somatostatin
|
TFF3
|
trefoil factor 3 (intestinal)
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
TRIM2
|
tripartite motif containing 2
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|